Drugs
Psychedelic research returns to Veterans Affairs
After decades, the Department of Veterans Affairs is once again investigating psychedelic therapies.
A new delivery method for drugs that can’t withstand stomach acid
In order for a drug to get to the small intestine, it must first get past the highly acidic environment of the stomach.
Yale study of DMT for depression is encouraging
Yale researchers have conducted a small study finding DMT is safe and tolerable enough for more research.
Magic mushrooms evolved to scramble insect brains, send them on wild, scary trips
Researchers discovered that the way fungi independently gained the ability to produce psilocybin is because of horizontal gene transfer.
New drug combo is “a paradigm shift” in preventing asthma attacks
The combination of a rescue medication and a corticosteroid, taken as needed, reduced both short and long-term risk of asthma attacks.
How we treat inflammation may be causing chronic pain
Reversing common belief, researchers at McGill say treating inflammation may be causing chronic pain, not preventing it.
‘Mad honey’: The rare hallucinogen from the mountains of Nepal
On the mountainsides of Nepal and Turkey, bees sometimes produce a strange and dangerous concoction: mad honey.
AI maps psychedelic “trip” experiences to regions of the brain – opening new route to psychiatric treatments
To better understand how these effects manifest in the brain, we analyzed over 6,000 written testimonials of hallucinogenic experiences.
How the antidepressant Prozac could treat blindness
Prozac is a widely used antidepressant. Data indicates that the drug could be used to prevent blindness due to macular degeneration.
90% of drugs fail clinical trials – here’s one way researchers can select better drug candidates
It’s disappointing when the years of effort and resources spent to push a drug candidate to patients so often lead to failure.